Puissance Capital Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Puissance Capital Management’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-905	Closed	-$31K	–	5
2020 Q1	$31K	Sell	905 -2,897	-76%	-$168K	0.36%	6
2019 Q4	$178K	Sell	3,802 -19,207	-83%	-$1.26M	0.44%	5
2019 Q3	$2.06M	Hold	23,009	–	–	4.59%	5
2019 Q2	$3.13M	Hold	23,009	–	–	3.06%	5
2019 Q1	$6.3M	Hold	23,009	–	–	5.13%	4
2018 Q4	$2.9M	Hold	23,009	–	–	3.31%	5
2018 Q3	$9.43M	Hold	23,009	–	–	6.59%	4
2018 Q2	$12.4M	Buy	23,009 +6,195	+37%	+$3.29M	9.35%	5
2018 Q1	$7.74M	Buy	+16,814	New	+$9.17M	6.67%	5

Other funds holding TCON

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

JJIJ

Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Puissance Capital Management's TCON Position: Q2 2020 in Review

Puissance Capital Management sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2020, closing a stake of 905 shares — an estimated $31K sold.

Puissance Capital Management first reported a position in TCON in Q1 2018 and held it in 9 quarters. The position peaked at $12.4M in Q2 2018. 18 funds tracked by Wall St. Rank hold TCON as of Q2 2020.

Puissance Capital Management reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Puissance Capital Management sold 905 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $31K.
Puissance Capital Management first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 9 quarters.
Puissance Capital Management's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $12.4M in Q2 2018.
18 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Puissance Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.